Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers

• Published in: Oncotarget Vol. 8; no. 8; pp. 13344 - 13356
• Main Authors: Zhong, Yali, Li, Xiaoli, Ji, Yasai, Li, Xiaoran, Li, Yaqing, Yu, Dandan, Yuan, Yuan, Liu, Jian, Li, Huixiang, Zhang, Mingzhi, Ji, Zhenyu, Fan, Dandan, Wen, Jianguo, Goscinski, Mariusz Adam, Yuan, Long, Hao, Bin, Nesland, Jahn M, Suo, Zhenhe
• Format: Journal Article
• Language: English
• Published: United States Impact Journals LLC 21.02.2017
• Subjects: Aged; Aged, 80 and over; Blotting, Western; Cell Line, Tumor; Flow Cytometry; Gene Knockout Techniques; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Neoplastic Stem Cells - enzymology; Neoplastic Stem Cells - pathology; Polymerase Chain Reaction; Prognosis; Prostatic Neoplasms - enzymology; Prostatic Neoplasms - mortality; Prostatic Neoplasms - pathology; Pyruvate Dehydrogenase (Lipoamide) - metabolism; Research Paper; prostate cancer; PDHA1; glycolysis; stemness
• ISSN: 1949-2553; 1949-2553
• DOI: 10.18632/oncotarget.14527

Cells generate adenosine-5'-triphosphate (ATP), the major currency for energy-consuming reactions, through mitochondrial oxidative phosphorylation (OXPHOS) and glycolysis. One of the remarkable features of cancer cells is aerobic glycolysis, also known as the "Warburg Effect", in which cancer cells rely preferentially on glycolysis instead of mitochondrial OXPHOS as the main energy source even in the presence of high oxygen tension. One of the main players in controlling OXPHOS is the mitochondrial gatekeeperpyruvate dehydrogenase complex (PDHc) and its major subunit is E1α (PDHA1). To further analyze the function of PDHA1 in cancer cells, it was knock out (KO) in the human prostate cancer cell line LnCap and a stable KO cell line was established. We demonstrated that PDHA1 gene KO significantly decreased mitochondrial OXPHOS and promoted anaerobic glycolysis, accompanied with higher stemness phenotype including resistance to chemotherapy, enhanced migration ability and increased expression of cancer stem cell markers. We also examined PDHA1 protein expression in prostate cancer tissues by immunohistochemistry and observed that reduced PDHA1 protein expression in clinical prostate carcinomas was significantly correlated with poor prognosis. Collectively, our results show that negative PDHA1 gene expressionis associated with significantly higher cell stemness in prostate cancer cells and reduced protein expression of this gene is associated with shorter clinical outcome in prostate cancers.